Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP
A patient may be a candidate for GLP-1 weight loss if they have obesity, overweight with weight-related health concerns, insulin resistance, prediabetes, type 2 diabetes risk, high blood pressure, high cholesterol, fatty liver concerns, sleep apnea risk, or repeated difficulty losing and maintaining weight with lifestyle changes alone
If pharmaceutical companies or researchers wanted to move this idea forward, it would require showing that leptin is adding a benefit on top of GLP-1s, said Jens Holst, a professor of physiology at the University of Copenhagen
What to Do If You Miss a Dose While Travelling Travel disruptions occasionally cause missed or delayed doses
Contact your prescriber if diarrhea persists beyond 4 weeks at a stable dose, is accompanied by blood, causes dehydration, or prevents adequate nutrition